Lineagen Aims At $15M Series B

Salt Lake City-based Lineagen, a developer of diagnostic and healthcare services, said today that it is in the midst of a $15M, Series B funding round. The firm said it is "progresisng towards a close" of the round, which currently includes Sanderling Ventures, vSpring Capital, PrairieGold Venture Partners and Mesa Verde Venture Partners. The firm said it has raised $5M of the Series B so far from those investors, who are all existing investors in the company. More information »